It’s just good to read the studies that are going on out there for inflammatory breast cancer. Here’s an excerpt from the article:
“The Cancer Institute at NYU Langone Medical Center have identified a key gene—eIF4G1—that is overexpressed in the majority of cases of IBC, allowing cells to form highly mobile clusters that are responsible for the rapid metastasis that makes IBC such an effective killer.”
“….there has been little progress in treating IBC over the past two decades, and there are no drugs specifically for this form of cancer. In fact, IBC has only recently been recognized as a unique, genetically distinct form of breast cancer.”
You can read more here.